Editorial Comment: Achieving Excellence in U.S. Cardiac Imagers by Providing Standardized Training.

AJR Am J Roentgenol

Professor, Yale School of Medicine, Division Chief Cardiothoracic Imaging, Department of Radiology & Biomedical Imaging, Yale New Haven Hospital, New Haven, CT.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.24.31784DOI Listing

Publication Analysis

Top Keywords

editorial comment
4
comment achieving
4
achieving excellence
4
excellence cardiac
4
cardiac imagers
4
imagers providing
4
providing standardized
4
standardized training
4
editorial
1
achieving
1

Similar Publications

Immo-bile-izing CD8 T cell anti-tumor immunity.

Immunity

March 2025

Blacktown Clinical School, Western Sydney University, Sydney, NSW 2148, Australia; Storr Liver Centre, Westmead Institute for Medical Research, Sydney, NSW 2145, Australia; Blacktown Mt Druitt Hospital, Sydney, NSW 2148, Australia. Electronic address:

Hepatocellular carcinoma is poorly responsive to immune checkpoint blockade. In a recent issue of Science, Varanasi et al. reveal how bile acids dampen anti-tumor CD8 T cell responses in the liver, contributing to cancer progression and poor immunotherapy outcomes.

View Article and Find Full Text PDF

RIPK3: The Deadpool of neuronal cell death proteins?

Immunity

March 2025

Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 S. 4th Street, Hamilton, MT 59840, USA. Electronic address:

Receptor interaction kinase 3 (RIPK3) is a key mediator of necroptosis, initiating programmed cell death with mercenary efficiency in multiple neurodegenerative diseases. However, in this issue of Immunity, Estevez et al. demonstrate that RIPK3, like the character Deadpool, exists in duality and can also be a force for good by preventing excitotoxic neuronal death during orthoflavivirus encephalitis.

View Article and Find Full Text PDF

The CREscendoing promise of HDAC targeting to limit atherosclerosis.

Immunity

March 2025

Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Electronic address:

The factors that modulate the inflammatory response in atherosclerosis are not well defined. In this issue of Immunity, Asare et al. examine the impact of a cis-regulatory element (CRE) that controls expression of HDAC9 and find that HDAC9-mediated deacetylation of NLRP3 might be the mechanism by which genetic variants in this conserved CRE influence the inflammation associated with human atherosclerosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!